- Recent Funding
- Investors
- Shunwei Capital
Shunwei Capital portfolio
Shunwei Capital has 8 portfolio companies on record at Recent Funding, with 1 investment in the last 12 months.
About this page
It is a venture capital firm based in Beijing, CN, founded in 2011. It led 1 of the 4 rounds it joined. Its most recent investment on record is Sleptay's Series A round in September 2026, alongside Morningside, Qianju Capital, Decheng Capital and 2 others. By category, its portfolio leans toward Health and bio (3) and Robotics and hardware (3). It has co-invested with Decheng Capital, Morningside and Huatai Zijin Investment.
About Shunwei Capital
What Shunwei Capital invests in
- Health and bio · 3 · 38%
- Robotics and hardware · 3 · 38%
- Logistics and mobility · 2 · 25%
- Manufacturing and industrial · 2 · 25%
- Consumer and social · 2 · 25%
- AI agents · 1 · 13%
- Foundation models and research · 1 · 13%
Shunwei Capital recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series A | Morningside, Qianju Capital, Decheng Capital (lead) +2 | ||
| Series B+ · lead | none named | ||
| Series B+ · $72.4M | CICC, China Development Bank Capital (lead), Junsan Capital +3 | ||
| Series B+ | WestBridge Capital (lead), Karina Choudhrie, BAce Capital +2 |
How Shunwei Capital invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 3 75% | $72.4M |
| Series A | 1 25% | undisclosed |
| Year | Deals | Capital in rounds |
|---|---|---|
| 2019 | 1 25% | undisclosed |
| 2023 | 1 25% | $72.4M |
| 2025 | 1 25% | undisclosed |
| 2026 | 1 25% | undisclosed |
Shunwei Capital portfolio companies
SSleptaySeries A · Sep 2026
VVelotricSeries B+ · Oct 2025
KKingsware$72.4MSeries B+ · Mar 2023
RRapidoSeries B+ · Jul 2019
FFAIRINObacker
SSAGE Intelligentbacker
YYongyuan BiotechbackerIINFevobacker
| Company | Round with Shunwei Capital | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A | undisclosed | Sep 28, 2026 Series A |
Logistics and mobility |
Series B+ · lead | $37.31M | Oct 16, 2026 Series B+ |
AI agents |
Series B+ · $72.4M | $72.4M | Mar 3, 2023 Series B+ |
Logistics and mobility |
Series B+ | $719.2M | May 15, 2026 Series B+ |
Robotics and hardware |
backer | $149.56M | Oct 16, 2026 Series B+ |
Robotics and hardware |
backer | undisclosed | Nov 3, 2026 Series B+ |
Health and bio |
backer | undisclosed | — |
Foundation models and research |
backer | $15M | Nov 16, 2026 Seed |
Most frequent co-investors
DDecheng Capital1 shared round · last Sep 28, 2026
MMorningside1 shared round · last Sep 28, 2026
HHuatai Zijin Investment1 shared round · last Sep 28, 2026
CChina Merchants Venture1 shared round · last Sep 28, 2026
- QQianju Capital1 shared round · last Sep 28, 2026
CCICC1 shared round · last Mar 3, 2023
CChina Development Bank Capital1 shared round · last Mar 3, 2023
JJunsan Capital1 shared round · last Mar 3, 2023
WWen's Investment1 shared round · last Mar 3, 2023
- ZZhengling Venture Capital1 shared round · last Mar 3, 2023
GGuangdong Yuecai Venture Capital Co., Ltd.1 shared round · last Mar 3, 2023
WWestBridge Capital1 shared round · last Jul 18, 2019
Similar investors
DDuquesne Family Office8 companies · 4 deals in 12 mo
NNRW.BANK8 companies · 4 deals in 12 mo
TTCG Crossover8 companies · 4 deals in 12 mo
TThe Column Group8 companies · 4 deals in 12 mo
TTransformation Capital8 companies · 4 deals in 12 mo
AAsabys Partners8 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Firm profile: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 4 rounds on Recent Funding that name Shunwei Capital. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Shunwei Capital, which is a subset of its real portfolio. API: /api/v1/investors/shunwei-capital (get a free API key). More: the most active VC firms and new venture capital funds.